{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:07:16Z","timestamp":1783811236990,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LPCC-TVi","award":["LPCC-TVi"],"award-info":[{"award-number":["LPCC-TVi"]}]},{"name":"iNOVA4Health","award":["Proj 21"],"award-info":[{"award-number":["Proj 21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Evol Biol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12862-018-1214-1","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T07:14:30Z","timestamp":1529392470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Sofia C.","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Lopes-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Gouveia-Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-5907","authenticated-orcid":false,"given":"Jacinta","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"1214_CR1","first-page":"29","volume":"65","author":"R Siegel","year":"2015","unstructured":"Siegel R, Miller K, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:29.","journal-title":"CA Cancer J Clin"},{"key":"1214_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-tieulent J, Jemal A. Global Cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"1214_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc2946","volume":"10","author":"DD Bowtell","year":"2010","unstructured":"Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer. 2010;10:803\u20138. Nature Publishing Group","journal-title":"Nat Rev Cancer"},{"key":"1214_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.AOG.0000231680.58221.a7","volume":"108","author":"JK Chan","year":"2006","unstructured":"Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006;108:521\u20138.","journal-title":"Obstet Gynecol"},{"key":"1214_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Sebastian Nat Rev. 2011;11:719\u201325.","journal-title":"Sebastian Nat Rev"},{"key":"1214_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","volume":"99","author":"H Itamochi","year":"2008","unstructured":"Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99:653\u20138.","journal-title":"Cancer Sci"},{"key":"1214_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003;3:502\u201316.","journal-title":"Nat Rev Cancer"},{"key":"1214_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"CKM Ip","year":"2016","unstructured":"Ip CKM, Li S, Tang MH, Sy SKH, Ren Y. Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress. Sci Rep. 2016;6:1.","journal-title":"Sci Rep"},{"key":"1214_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S1470-2045(11)70123-1","volume":"12","author":"SL Cooke","year":"2011","unstructured":"Cooke SL, Brenton JD, Way R. Evolution of platinum resistance in high-grade serous ovarian cancer. Lancet Oncol. 2011;12:1169\u201374. Elsevier Ltd","journal-title":"Lancet Oncol"},{"key":"1214_CR10","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T, et al. Clinical characteristics of clear cell carcinoma of the ovary. Cancer. 2000;88:2584\u20139.","journal-title":"Cancer"},{"key":"1214_CR11","doi-asserted-by":"crossref","unstructured":"Goff BA, de la Cuesta RS, Muntz HG, Fleischhacker D, Ek M, Rice LW, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 1996;417:412\u20137.","DOI":"10.1006\/gyno.1996.0065"},{"key":"1214_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4161\/cc.10.2.14476","volume":"10","author":"J Serpa","year":"2011","unstructured":"Serpa J, Dias S. Metabolic cues from the microenvironment act as a major selective factor for cancer progression and metastases formation. Cell Cycle. 2011;10:180\u20131.","journal-title":"Cell Cycle"},{"key":"1214_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. Elsevier Inc","journal-title":"Cell"},{"key":"1214_CR14","doi-asserted-by":"publisher","unstructured":"Almendros I, Gozal D. Intermittent hypoxia and cancer: undesirable bed partners?Respir Physiol Neurobiol; 2017. https:\/\/doi.org\/10.1016\/j.resp.2017.08.008 .","DOI":"10.1016\/j.resp.2017.08.008"},{"key":"1214_CR15","first-page":"28418511769999","volume":"0","author":"SG Mikalsen","year":"2017","unstructured":"Mikalsen SG, Jeppesen Edin N, Sandvik JA, Pettersen EO. Separation of two sub-groups with different DNA content after treatment of T-47D breast cancer cells with low dose-rate irradiation and intermittent hypoxia. Acta Radiol. 2017;0:28418511769999.","journal-title":"Acta Radiol"},{"key":"1214_CR16","doi-asserted-by":"publisher","first-page":"44693","DOI":"10.1038\/srep44693","volume":"7","author":"N Campillo","year":"2017","unstructured":"Campillo N, Torres M, Vilaseca A, Nonaka PN, Gozal D, Roca-Ferrer J, et al. Role of Cyclooxygenase-2 on intermittent hypoxia-induced lung tumor malignancy in a mouse model of sleep apnea. Sci Rep. 2017;7:44693. Nature Publishing Group","journal-title":"Sci Rep"},{"key":"1214_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2016.10.002","volume":"101","author":"K Gutsche","year":"2016","unstructured":"Gutsche K, Randi EB, Blank V, Fink D, Wenger RH, Leo C, Scholz CC. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-\u03baB in inflammatory breast cancer cells. Free Radic Biol Med. 2016;101:129\u201342.","journal-title":"Free Radic Biol Med"},{"key":"1214_CR18","doi-asserted-by":"crossref","unstructured":"Cutter NL, Walther T, Gallagher L, Lucito R, Wrzeszczynski K. Hypoxia signaling pathway plays a role in ovarian cancer chemoresistance. Adv. Ovarian Cancer Res. Exploit. Vulnerabilities. 2016.","DOI":"10.1158\/1557-3265.OVCA15-A24"},{"key":"1214_CR19","doi-asserted-by":"publisher","first-page":"e79167","DOI":"10.1371\/journal.pone.0079167","volume":"8","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, et al. Cystathionine Beta-synthase (CBS) contributes to advanced ovarian Cancer progression and drug resistance. PLoS One. 2013;8:e79167.","journal-title":"PLoS One"},{"key":"1214_CR20","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1073\/pnas.1306241110","volume":"110","author":"C Szabo","year":"2013","unstructured":"Szabo C, Coletta C, Chao C, M\u00f3dis K, Szczesny B, Papapetropoulos A. Tumor-derived hydrogen sulfide, produced by cystathionine- \u03b2 -synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. PNAS Pharmacol. 2013;110:12474\u20139.","journal-title":"PNAS Pharmacol"},{"key":"1214_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","volume":"86","author":"S Sen","year":"2015","unstructured":"Sen S, Kawahara B, Gupta D, Tsai R, Khachatryan M, Farias-eisner R, et al. Role of cystathionine \u03b2 -synthase in human breast Cancer. Free Radic Biol Med. 2015;86:228\u201338.","journal-title":"Free Radic Biol Med"},{"key":"1214_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/pcmr.12312","volume":"28","author":"E Panza","year":"2015","unstructured":"Panza E, De Cicco P, Armogida C, Scognamiglio G, Gigantino V, Botti G, et al. Role of the cystathionine \u03b3 lyase\/hydrogen sulfide pathway in human melanoma progression. Pigment Cell Melanoma Res. 2015;28:61\u201372.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1214_CR23","doi-asserted-by":"publisher","first-page":"166.e15","DOI":"10.1016\/j.urolonc.2015.06.020","volume":"34","author":"JW Gai","year":"2016","unstructured":"Gai JW, Qin W, Liu M, Wang HF, Zhang M, Li M, et al. Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder. Urol Oncol Semin Orig Investig. 2016;34:166.e15\u201320.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"1214_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1667\/RR14177.1","volume":"185","author":"Y Pan","year":"2015","unstructured":"Pan Y, Zhou C, Yuan D, Zhang J, Shao C. Radiation exposure promotes Hepatocarcinoma cell invasion through epithelial Mesenchymal transition mediated by H2S\/CSE pathway. Radiat Res. 2015;185:96\u2013105.","journal-title":"Radiat Res"},{"key":"1214_CR25","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1007\/s13277-015-4290-5","volume":"37","author":"F Lopes-Coelho","year":"2016","unstructured":"Lopes-Coelho F, Gouveia-Fernandes S, Gon\u00e7alves LG, Nunes C, Faustino I, Silva F, et al. HNF1B drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC). Tumor Biol. 2016;37:4813\u201329.","journal-title":"Tumor Biol"},{"key":"1214_CR26","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/1097-0142(20001001)89:7<1440::AID-CNCR5>3.0.CO;2-0","volume":"89","author":"T Schnelldorfer","year":"2000","unstructured":"Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer. 2000;89:1440\u20137.","journal-title":"Cancer"},{"key":"1214_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cbf.1149","volume":"22","author":"GK Balendiran","year":"2004","unstructured":"Balendiran GK, Dabur R, Fraser D. The role of glutathione in cancer. Cell Biochem Funct. 2004;22:343\u201352.","journal-title":"Cell Biochem Funct"},{"key":"1214_CR28","first-page":"1737","volume":"4","author":"J Kigawa","year":"1998","unstructured":"Kigawa J, Minagawa Y, Cheng X, Terakawa N. Y-Glutamyl cysteine synthetase up-regulates multidrug resistance-associated protein in patients with chemorresistant epithelial ovarian cancer. Clin Cancer Res. 1998;4:1737\u201341.","journal-title":"Clin Cancer Res"},{"key":"1214_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573\u201384.","journal-title":"Nat Rev Cancer"},{"key":"1214_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"ACR Epstein","year":"2001","unstructured":"Epstein ACR, Gleadle JM, McNeill LA, Hewitson KS, O\u2019Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43\u201354.","journal-title":"Cell"},{"key":"1214_CR31","doi-asserted-by":"publisher","unstructured":"Wu D, Yotnda P. Induction and testing of hypoxia in cell culture. J Vis Exp. 2011(54). https:\/\/doi.org\/10.3791\/2899 .","DOI":"10.3791\/2899"},{"key":"1214_CR32","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.2849206","volume":"242","author":"MA Goldberg","year":"1988","unstructured":"Goldberg MA, Dunning SPBH. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science. 1988;242:1412\u20135.","journal-title":"Science"},{"key":"1214_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jscs.2010.02.005","volume":"14","author":"MS Al Okail","year":"2010","unstructured":"Al Okail MS. Cobalt chloride, a chemical inducer of hypoxia-inducible factor-1\u03b1 in U251 human glioblastoma cell line. J Saudi Chem Soc. 2010;14:197\u2013201. Japanese Association for Dental Science","journal-title":"J Saudi Chem Soc"},{"key":"1214_CR34","doi-asserted-by":"publisher","first-page":"15911","DOI":"10.1074\/jbc.M300463200","volume":"278","author":"Y Yuan","year":"2003","unstructured":"Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-\u03b1 and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-\u03b1. J Biol Chem. 2003;278:15911\u20136.","journal-title":"J Biol Chem"},{"issue":"3","key":"1214_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02921498","volume":"19","author":"AE Ghaly","year":"1988","unstructured":"Ghaly AE, Kok R. The effect of sodium sulfite and cobalt chloride on the oxygen transfer coefficient. Appl Biochem Biotechnol. 1988;19(3):259\u201370.","journal-title":"Appl Biochem Biotechnol"},{"key":"1214_CR36","first-page":"438","volume":"19","author":"J Tammela","year":"1998","unstructured":"Tammela J, Geisler J, Eskew PJ, Geisler H. Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma. Eur J Gynaecol Oncol. 1998;19:438\u201340.","journal-title":"Eur J Gynaecol Oncol"},{"key":"1214_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ygyno.2011.05.009","volume":"122","author":"Y Lee","year":"2011","unstructured":"Lee Y, Kim T, Kim M, Kim H, Song T, Kyu M, et al. Gynecologic oncology prognosis of ovarian clear cell carcinoma compared to other histological subtypes\u00a0: a meta-analysis. Gynecol Oncol. Elsevier Inc. 2011;122:541\u20137.","journal-title":"Gynecol Oncol"},{"key":"1214_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev.es.19.110188.001231","volume":"19","author":"DJ Futuyma","year":"1988","unstructured":"Futuyma DJ, Moreno G. The evolution of ecological specialization. Annu Rev Ecol Evol Syst. 1988;19:207\u201333.","journal-title":"Annu Rev Ecol Evol Syst"},{"key":"1214_CR39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1086\/506527","volume":"168","author":"M Novak","year":"2006","unstructured":"Novak M, Pfeiffer T, Lenski RE, Sauer U, Bonhoeffer S. Experimental tests for an evolutionary trade-off between growth rate and yield in E. Coli. Am Nat. 2006;168:242\u201351.","journal-title":"Am Nat"},{"key":"1214_CR40","doi-asserted-by":"publisher","first-page":"8649","DOI":"10.1073\/pnas.0702117104","volume":"104 Suppl","author":"AF Bennett","year":"2007","unstructured":"Bennett AF, Lenski RE. An experimental test of evolutionary trade-offs during temperature adaptation. Proc Natl Acad Sci USA. 2007;104 Suppl:8649\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1214_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2307\/2389364","volume":"3","author":"S Stearns","year":"1989","unstructured":"Stearns S. Trade-offs in life-history evolution. Funct Ecol. 1989;3:259\u201368.","journal-title":"Funct Ecol"},{"issue":"51","key":"1214_CR42","doi-asserted-by":"publisher","first-page":"41928","DOI":"10.1074\/jbc.M508718200","volume":"280","author":"H Lu","year":"2005","unstructured":"Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem. 2005;280(51):41928\u201339.","journal-title":"J Biol Chem"},{"key":"1214_CR43","doi-asserted-by":"crossref","unstructured":"Briggs, K. J., Koivunen, P., Cao, S., Backus, K. M., Olenchock, B. A., Patel, H., ... & Witkiewicz, A. K. Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine Cell 2016; 166(1), 126\u2013139.","DOI":"10.1016\/j.cell.2016.05.042"},{"key":"1214_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrc3606","volume":"13","author":"CA Aktipis","year":"2013","unstructured":"Aktipis CA, Boddy AM, Gatenby RA, Brown JS, Maley CC. Life history trade-offs in cancer evolution. Nat Rev Cancer. 2013;13:883\u201392.","journal-title":"Nat Rev Cancer"},{"key":"1214_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"1214_CR46","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jcb.22214","volume":"107","author":"K Ruan","year":"2009","unstructured":"Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem. 2009;107:1053\u201362.","journal-title":"J Cell Biochem"},{"key":"1214_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"issue":"11","key":"1214_CR48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc3803","volume":"14","author":"SS Sabharwal","year":"2014","unstructured":"Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel? Nat Rev Cancer. 2014;14(11):709.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1214_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/CIRCRESAHA.109.206334","volume":"106","author":"GB Waypa","year":"2010","unstructured":"Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, Schumacker PT. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ Res. 2010;106(3):526\u201335.","journal-title":"Circ Res"},{"issue":"2","key":"1214_CR50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ccell.2015.01.007","volume":"27","author":"PT Schumacker","year":"2015","unstructured":"Schumacker PT. Reactive oxygen species in cancer: a dance with the devil. Cancer Cell. 2015;27(2):156\u20137.","journal-title":"Cancer Cell"},{"issue":"11","key":"1214_CR51","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1089\/ars.2011.4414","volume":"16","author":"SC Gupta","year":"2012","unstructured":"Gupta SC, et al. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal. 2012;16(11):1295\u2013322.","journal-title":"Antioxid Redox Signal"}],"container-title":["BMC Evolutionary Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12862-018-1214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12862-018-1214-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12862-018-1214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T13:16:17Z","timestamp":1571490977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcevolbiol.biomedcentral.com\/articles\/10.1186\/s12862-018-1214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1214"],"URL":"https:\/\/doi.org\/10.1186\/s12862-018-1214-1","relation":{},"ISSN":["1471-2148"],"issn-type":[{"value":"1471-2148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental procedures were developed in in vitro assays, no human or animal samples and models were used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent the publication of the scientific paper by BMC Evolutionary Biology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"97"}}